Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - TOTAL OTHER INCOME
Total Other Income REGN - Regeneron Pharmaceuticals, Inc.
789 M
LAST VALUE
156.56%
2 YEAR CAGR
29.19%
5 YEAR CAGR
30.74%
10 YEAR CAGR